We are excited to bring you a new episode of "The One Away Show" with Bryan Wish which featured our Founder and CEO, Neil Littman! Here he discussed investing in causes one believes in, being motivated by impacting more people's lives, financial opportunities in the healthcare industry, as well as ...
Continue Reading >Neil is the Founder & CEO of Bioverge Ventures, an investment platform democratizing access to enable individuals to diversify their portfolio with private biotech and healthcare investments for the purposes of long-term wealth creation.
Continue Reading >Healthcare and medicine have long served as a hotbed of innovation. Perhaps the leading edge these days requires a paradigm shift – think digital therapeutics, Web3, the metaverse, CRISPR, Software as a Medical Device – this is the domain of Neil Littman, Founder & CEO of Bioverge, a highly curated impact-investment venture platform exclusively dedicated to healthcare and to democratizing access to investing in early stage companies and startups. The Bioverge platform serves as a decentralized network linking capital to potential investment opportunities.
Continue Reading >Bioverge is an investment and engagement platform that aims to connect the world to startup companies transforming healthcare. We’re living at an exciting time - the convergence of biology and technology is rapidly driving the healthcare industry in exciting new directions – making patient care more effective, accessible, personalized, cheaper, and faster. If you could gift the world anything, wouldn't the most impactful be the gift of better health?
Continue Reading >The investing world is rapidly evolving. Investors can now invest in private healthcare and biotech companies that were once the exclusive domain of professional investors.
Continue Reading >Healthcare provides another avenue in which investors can do well by doing good.
Continue Reading >"The average person will never get the chance to invest in a future unicorn like Moderna: The type of private equity deals that brought the now-famous biotech to the world are done in country clubs and coffee houses in a select few places, leaving anyone who is not a hedge fund manager, venture capitalist or disgustingly rich individual out of the game."
Continue Reading >Even as venture capital last year poured $28.5 billion into biotech companies globally and biotech IPOs raised more than $5 billion in the first quarter of this year alone, Neil Littman says he saw both a disturbing trend, as well as a potential opportunity. Investors focused more capital into larger ...
Continue Reading >Venture capital-style investments offer the potential for bigger upside and more diversification
Continue Reading >Neil Littman is the Founder of Bioverge, a highly curated impact investment platform exclusively dedicated to healthcare. Bioverge enables a motivated public to finance and support the health-related causes and companies most important to them. Previously, Neil was a member of the Executive Leadership Team and Director ...
Continue Reading >